Vignir Helgason
16PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Feb 24, 2026
A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.Ekaterini Himonas, Lucie de Beauchamp, Désirée Zerbst
|Jun 12, 2024
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia.Ahmed Khalaf, Lucie de Beauchamp, Eric Kalkman
|Mar 02, 2024
Inhibition of mitochondrial folate metabolism drives differentiation through mTORC1 mediated purine sensing.Martha M Zarou, Kevin M Rattigan, Daniele Sarnello
|Feb 05, 2024
Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche.Amy Dawson, Martha M Zarou, Bodhayan Prasad
|Aug 17, 2023
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells.Kevin M Rattigan, Zuzana Brabcova, Daniele Sarnello
|Jul 25, 2023
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells.Kevin M Rattigan, Martha M Zarou, Zuzana Brabcova
Pageof 3
Frequent Collaborators
7 joint publications
Mhairi Copland
7 joint publications
Martha M Zarou
6 joint publications
Kevin Rattigan
5 joint publications
Karen Dunn
5 joint publications
David Sumpton
5 joint publications
Mary T Scott
4 joint publications
Ekaterini Himonas
4 joint publications
Eric R Kalkman
3 joint publications
Alison M Michie
3 joint publications
David Vetrie
